JPRN-UMIN000020272已完成未知
Bioequivalence study of the consumption of plant-derived processed product with anti-obesity in healthy adults - Bioequivalence study of plant-derived processed product in healthy adults.
ew Drug Research Center, Inc.0 个研究点目标入组 17 人开始时间: 2016年1月20日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 17
研究概览
简要总结
he result suggested that there was bioequivalence between test food and control food.
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 35years-old 至 65years-old(—)
- 性别
- All
入选标准
- 未提供
排除标准
- •1) individual with liver, kidney and heart disease, or disorder of respiration, endocrine, metabolism, nervous system, consciousness, or diabetes, or other diseases, 2) individual given surgery within 2 months before the trial, 3) medicine user for hyperglycaemia, lipidemia, or hypertension, 4) individual intakes supplements or the food for specific use of health authorized the government, 5) individual experienced unpleasant feeling during blood drawing, 6) individual donated 200 mL or more blood within 1 month before the trial, 7) heavy smoker (cigarettes>=21/day), 8) shiftworker, 9) individual plans bussiness trip for 10 consecutive days or more, 10) individual had allergy against any constituents in the test diet, 11) individual can not conform to record of daily diet for 6 days (3 days x 2 times), 12) individual cannot allow operator to consult his/her data of the past health check, 13) individual have already participated other clinical trial and will participate, 14) pregnant women or breast-feeding women, 15) individual who was judged ineligibles by clinician in this trial
研究者
相似试验
已完成
不适用
Bioequivalence study of foodot applicableJPRN-UMIN000029771SUNTORY MONOZUKURI EXPERT LIMITED24
已完成
不适用
Bioequivalence study of foodot applicableJPRN-UMIN000023907Suntory Business Expert Limited24
已完成
不适用
Bioequivalence study of foodot applicableJPRN-UMIN000030017SUNTORY GLOBAL INNOVATION CENTER LIMITED15
已完成
1 期
A Study of Baricitinib in Healthy ParticipantsHealthyNCT03212638Eli Lilly and Company42
已完成
1 期
Open Label, Healthy Volunteers, Bioequivalence Study With NaloxegolOpioid Induced ConstipationNCT01623609AstraZeneca42
